
Wyllians Borelli
@vbwyll
Followers
818
Following
3K
Media
67
Statuses
690
professor, clinician-scientist, neurologist. interested in cognitive reserve and glia. @alzassociation @zimmerneurolab @ufrgsnoticias
earth
Joined October 2017
RT @borelli_lab: You never forget your first time 💚.The @borelli_lab team is heading for the first time to #AAIC2025, the world’s biggest e….
0
1
0
RT @AgustinMIbanez: In a world facing political turmoil, social exposomes, and pollution, our study reveals that these forces accelerate ag….
0
11
0
RT @borelli_lab: Dr. @vbwyll in action at @congressobrain, presenting on blood biomarkers for Alzheimer’s disease 🧠🩸 — discussing when and….
0
1
0
Excited to announce this new step!. 🧠.
👋 Hello, nice to meet you — we’re just getting started!. We are a research group led by Dr. @vbwyll, dedicated to studying Alzheimer’s and related dementias 🧠. Our mission: advance prevention, early diagnosis, and treatment through neuroscience!
0
0
5
GLP-1 agonists seem to benefit individuals with abusive behavior - food intake, alcohol, drugs. Will it work in #AD?.
GLP-1 agonists semaglutide and liraglutide may be effective in the treatment of alcohol use disorder.
0
0
5
RT @brnovsk: Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country….
0
11
0
RT @zimmerneurolab: Last week, the XXXI Brazilian Congress of Neurology took place, the largest event in this field in 🇧🇷! Organized by ABN….
0
1
0
It’s amazing to hear an inspiring, brilliant researcher that encourage the whole Brazilian community to keep researching.
The spectacular @grinberg_t explaining why we should study sleep in brain aging and dementia at #CBN2024 😴💤🛌🥱
0
0
11
RT @AgustinMIbanez: Precision brain health can evolve by integrating computational frameworks of brain clocks + multimodal diversity, showi….
0
27
0
RT @Elisa_Resende_: Part of the task force that published the guidelines for the use of AD biomarkers and potential use of anti-amyloid the….
0
3
0
Glad to contribute with the national consensus.
Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country with significant challenges. I am glad to have led this task force with colleagues and mentors. Articles available at @DementiaNeuro (links below)
0
0
20
Palestra incrÃvel do @leandrominozzo sobre a polÃtica nacional de cuidado integral a pessoas com doença de Alzheimer e outras demências. Muita coisa boa para celebrar! @erzimmer e #nitrini em foco
1
0
19
There is something interesting in targeting neuroinflammation in Alzheimer’s - potential indications for other diseases.
thelancet.com
Our research suggested that GLP-1 agonists were associated with a lower risk of dementia compared to sulfonylureas and DPP-4 inhibitors in older individuals with T2DM. Further clinical trials are...
0
4
19
During my first ISTAART advisory council meeting, it was clear that everyone was sad that @CaramelliPaulo was leaving, though happy that @claire_e_sexton , @ozy_ismail @alladi_suvarna and #Zetterberg were leading the council. I am incredibly thankful for this opportunity.
It has been a privilege to serve on the @ISTAART advisory council. I have learned so much from experts in the field (some pictured here at #AAIC24) & look forward to paying this forward. Thank you @alzassociation @claire_e_sexton & @ozy_ismail for this incredible opportunity! 💜
0
0
17
PREVENTION!.
High LDL*Cholesterol and Visual.Impairment added to risk factors for dementia by the @TheLancet Commission on dementia, Intervention and Care 2024 👇👇👇👇.
0
0
9